newsare.net
The US Food and Drug Administration has told Moderna it requires more time to rule on whether to approve its jab for children aged between 12 and 17, so it can evaluate reported risks of rare side effects, the drugmaker has said. Read Full Article at RT.comFDA tells Moderna it needs ‘additional time’ to evaluate use of its vaccine for teens because of rare cases of heart inflammation
The US Food and Drug Administration has told Moderna it requires more time to rule on whether to approve its jab for children aged between 12 and 17, so it can evaluate reported risks of rare side effects, the drugmaker has said. Read Full Article at RT.com Read more











